Do you think it would be possible to get the ethical committee/ trial board approval of your institution to start a long term CV outcome trial on #Flozins in transplant ? #NephJC

Hi, this is Assad , Nephrologist and transplant physician from India. No COI. We have a small cohort of transplant recipients whom we Flozinate, primarily for Proteinuria. #NephJC

T3d Benefits may vary, and results in the general population on CV risk and mortality are still controversial. Overall, the results of recent studies have been mixed results. Different study populations, end points and dosing may account for the lack of clarity. #NephJC

Hey I’m Assad, nephrologist working in a high-volume IgAN centre in India ! We’re still like the KDIGO guidleimes though - a bit outdated as we come up ! Probably it’s the cost of these drugs and their availability which limit us ! No COI #NephJC

Ongoing late posts from @theisn.org #ISNWCN from the high impact trial session - this was a great study design The India ALLIANCE GRACE IgAN trial Lead by Succeena Alexander from CMC Vellore #NephSky 1/

These are the interventions: - SoC alone - Low dose steroids - Gut directed (NOT targeted release) budesonide - MMF - Hydroxychloroquine - later Finerenone once generic in India Great choices! #NephSky #ISNWCN 4/

Treatment in children: 👶💉 Management is based on RAS blockade, salt restriction, and blood pressure control. Glucocorticoids are used in those with persistent proteinuria or high-risk features, sometimes combined with cyclophosphamide in severe cases. #NephJC

Yes my exact opinion, guidelines may be evolving and improving but what happens in reality? Our patients either come with a creat of 8, Or they’re loaded with steroids for quite long without even SGLT2i or ARBs many times, and they’re just victims of therapeutic misadventure. Sorry state. #NephJC

Hey this is S M Assad, Assistant Prof Nephrology from CMC Vellore ! #NephJC In India, many with IgAN present late and do poorly—limited access, high costs, and low awareness keep outcomes far behind what they could be. Also the fact that the eGFR slope is somehow too deep. No COI

Hey this is Assad, nephrologist from Christian Medical College, Vellore in India. We tend to restrict proteins in our patients, and they go a few steps further stopping all protein altogether - ending up cachexic. Change is warranted. Most of our patients are traditionally vegetarian too🥑 #NephJC

But I don’t see it going beyond the small privileged group of HLA matched patients ! There are too many IFs and BUTs involved #NephJC

The problem here is that - as attractive as being IS free sounds - it comes with a huge load right from patient selection, ensuring HLA compatibility, putting a huge burden on donors (making the MDR 101) and a very high risk IS withdrawal trial - with risk of rejection for the KTRs #NephJC

This is a once-a-year plea for support #NephJC

Check out the insightful summary by Dr Akshaya Jayachandran @nephromommy-akshu.bsky.social and Dr Natalia Nombera @roxnonna23.bsky.social #NephJC

Hey, I'm S M Assad, young Nephrologist from CMC Vellore, India. No COI. While some centers in India have explored steroid-free regimens and local stem-cell work, the complexity and cost of bespoke cell therapies mean we rely on conventional, cost-effective IS as the standard of care. #NephJC

It was. The book is focuses on the history of TB, but it’s definitely not historical. In India, it’s our present. TB plagues all communities and classes, and it’s probably nothing to be proud of, that I seem to know and see most of these situations day-in and out ! #NephJC

Beautiful and meaningful poem by @nephromommy-akshu.bsky.social inspired by @johngreensbluesky.bsky.social's Everything is Tuberculosis www.nephjc.com/news/2025/8/...

On 7/22/25 at 9pm EST only on Bluesky! #NephSky #MedSky join us for a lively discussion. We're debating eGFRdiff (the gap that is sometimes present between the eGFR of cystatin C and creatinine). What does it mean, what causes it and what you should do about it. #NephJC www.nephjc.com/news/egfrdiff

Check out the VA from @drsaivani.bsky.social and @nephromommy-akshu.bsky.social on eGFRdiff in the CRIC cohort. #Nephsky #NephJC www.nephjc.com/news/cricdiff

Hi I’m Assad, practising nephrologist from India, Flozinator but not a finerator (yet) ! My first #NephJC chat ! No COI

Attended #KSN2025 in Seoul 🇰🇷! Presented two posters at the conference! 👩🏻‍⚕️ A scintillating experience soaking in all the science, savouries and Seoul skies !! 😃🎏🥋🍜@assadsm.bsky.social #nephrology #KSN #seoul #nephroconference

Attended @ksnmeeting 2025 at Seoul and had the opportunity to present my poster at the conference! Thrilled by the city’s vibrant cultural and modern landscape!! @nephromommy-akshu.bsky.social #nephrology #KSN #seoul #nephroconference

The class of 2025, #NephJC interns www.nephjc.com/news/2025/6/...

Follow them all here: go.bsky.app/7qJxtg

And Team B: #NephJC @glomerican.bsky.social @bogdan-agavriloaei.bsky.social @nephromommy-akshu.bsky.social @DrSaiVani.bsky.social @roxnonna23.bsky.social

Welcome next #NephJC generation! New NephJC authors & creators debuting in July 2025, check them out & give them a follow! 📸 Team A: @sejalplakhani.bsky.social @notjustdialysis.bsky.social @msocomd.bsky.social @shelliefravel.bsky.social @salinesolut.bsky.social @jeyakimarmeyyappan.bsky.social